James Investment Research Inc Biogen Inc. Transaction History

James Investment Research Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 30, 2023	BUY	$252.44 - $306.72 $25,748 - $31,285	102 New	102 $28,000
Q2 2019 Jul 24, 2019	SELL	$219.29 - $241.72 $482,438 - $531,784	-2,200 Closed	0 $0
Q1 2019 Apr 26, 2019	BUY	$216.71 - $338.96 $476,762 - $745,712	2,200 New	2,200 $520,000
Q1 2018 Apr 12, 2018	SELL	$260.13 - $367.91 $1.4 Million - $1.99 Million	-5,400 Closed	0 $0
Q4 2017 Jan 23, 2018	SELL	$307.64 - $344.58 $123,056 - $137,832	-400 Reduced 6.9%	5,400 $1.72 Million
Q3 2017 Oct 13, 2017	BUY	$281.15 - $329.69 $1.63 Million - $1.91 Million	5,800	5,800 $1.82 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

Stay updated on James Investment Research Inc with notifications on news.